Physician profile
Robert N Greene
NPI 1952350639
$10,786.99
in general payments reported to CMS, 2019-2025
9 companies · $750 in 2025
The $750 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,036 · 2020: $485 · 2021: $1,720 · 2022: $1,542 · 2023: $2,392 · 2024: $862 · 2025: $750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,504 · Honoraria: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,503.60 |
| Honoraria | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $6,992.14 | 2019-2025 | Mako, Pangea, Gamma |
| Encore Medical, LP | $1,856.06 | 2021-2023 | |
| Pacira Pharmaceuticals Incorporated | $1,696.76 | 2019 | |
| Medacta USA, INC. | $132.82 | 2020 | |
| Heron Therapeutics, INC. | $39.94 | 2023 | Zynrelef |
| Boston Scientific Corporation | $25.86 | 2025 | Lithovue |
| Amniox Medical, INC. | $19.54 | 2019 | |
| Sanofi Pasteur INC. | $12.48 | 2019 | |
| Kci USA, INC. | $11.39 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Greene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.